Friday, 3 February 2017


Strides Shasun, a pharmaceutical company today posted its Q3 results on Friday. The stock soon after jumped by 15% owing to sharp upsurge in net profit. The company is also in the process of merging its API business with Sequent Scientific.

The company’s EBITDA is up by 29.8% at Rs 198 crore vs Rs 153 crore (YoY). The EBITDA margin is 21.2% vs 17.6% (YoY). Whereas, the total income is up by 7.7% at Rs 934 crore vs Rs 867 crore (YoY). Net profit stands at Rs 187.3 cr vs Rs 58.9 cr (YoY).

The current market capitalisation of the company stands at Rs 10,761.78 crore. In a period of one year the stock has delivered a return of 39.51%, outperforming the BSE Healthcare index and underperforming the BSE mid-cap index over the same time period. Strides Shasun Ltd ended at Rs 1194.3, up by Rs 114 or 10.55% from its previous closing of Rs 1080.3 on the BSE.

The scrip opened at Rs 1100 and touched a high and low of Rs 1259 and Rs 1093 respectively. A total of 3775705(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 9654.5 crore.

The BSE group 'A' stock of face value Rs 10 touched a 52 week high of Rs 1215 on 16-May-2016 and a 52 week low of Rs 848 on 29-Feb-2016. Last one week high and low of the scrip stood at Rs 1150 and Rs 1052.95 respectively. The promoters holding in the company stood at 31.14 % while Institutions and Non-Institutions held 49.05 % and 19.81 % respectively. The stock traded above its 50 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

0 comments: